Marine Bio (NASDAQ: MBII) reported Q1 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.05 million.

For earnings history and earnings-related data on Marine Bio (MBII) click here.